Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von PapaSmurf 

Cardinal Health Inc. diskutieren

Cardinal Health Inc.

WKN: 880206 / Symbol: CAH / Name: Cardinal Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /

90,88 €
-1,00 %

Buy Cardinal Health Inc.

Einschätzung Buy
Rendite (%) 11,82 %
Kursziel 99,05
Veränderung
Endet am 16.08.24

Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Robert W. Baird from $107.00 to $108.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) 11,82 %
Kursziel 91,68
Veränderung
Endet am 16.08.24

Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Morgan Stanley from $92.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Sell
Rendite (%) -5,25 %
Kursziel 87,70
Veränderung
Endet am 14.12.24

Cardinal Health, Inc. (NYSE: CAH) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $96.00 price target on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,22 %
Kursziel 107,10
Veränderung
Endet am 03.01.25

Cardinal Health, Inc. (NYSE: CAH) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $117.00 price target on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) -6,92 %
Kursziel 112,87
Veränderung
Endet am 29.01.25

Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at UBS Group AG from $114.00 to $122.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,28 %
Kursziel 116,35
Veränderung
Endet am 05.02.25

Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at UBS Group AG from $122.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat

Cardinal Health, Inc. (NYSE: CAH) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Ratings data for CAH provided by MarketBeat

Cardinal Health, Inc. (NYSE: CAH) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Ratings data for CAH provided by MarketBeat

Einschätzung Sell
Rendite (%) -5,10 %
Kursziel 87,66
Veränderung
Endet am 29.04.25

Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Wells Fargo & Company from $96.00 to $94.00. They now have an "underweight" rating on the stock.
Ratings data for CAH provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,72 %
Kursziel 118,58
Veränderung
Endet am 03.05.25

Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Robert W. Baird from $134.00 to $128.00. They now have an "outperform" rating on the stock.
Ratings data for CAH provided by MarketBeat